Keyword: Imbruvica

News

AbbVie Completes Pharmacyclics Acquisition

28.05.2015 - AbbVie has completed the acquisition of Pharmacyclics, a deal the Chicago-based US drugmaker says enhances its scientific and commercial presence in oncology. As a wholly owned...

News

AbbVie to Acquire Pharmacyclics for $21 Billion

05.03.2015 - US drugmaker AbbVie has reached final agreement to acquire compatriot Pharmacyclics and the company's flagship asset Imbruvica (ibrutinib), which it describes as "a highly...